compound 19 [PMID: 35142215]   Click here for help

GtoPdb Ligand ID: 11903

Compound class: Synthetic organic
Comment: This compound was discovered as a noncovalent coronavirus Mpro inhibitor in a virtual screening campaign of >200 million fragments, followed by crystallographic screening and hit-to-lead optimisation [1]. Binding to the SARS-CoV-2 Mpro and inhibition of its protease activity were confirmed in in vitro assays.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 2
Topological polar surface area 62.3
Molecular weight 377.09
XLogP 3.49
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C1NC2(C(=O)N1c1cncc3c1cccc3)CC(C2)c1ccccc1Cl
Isomeric SMILES Clc1c(cccc1)C1CC2(C1)NC(=O)N(C2=O)c1c2ccccc2cnc1
InChI InChI=1S/C21H16ClN3O2/c22-17-8-4-3-6-15(17)14-9-21(10-14)19(26)25(20(27)24-21)18-12-23-11-13-5-1-2-7-16(13)18/h1-8,11-12,14H,9-10H2,(H,24,27)
InChI Key XQFMLNUPNCXPRN-UHFFFAOYSA-N
Bioactivity Comments
Compound 19 did not inhibit a set of human proteases (cathepsins K, D, B, L, thrombin, caspase-2, elastase, calpain 1, trypsin), and its cytotoxicity was low against human Vero E6 and Huh7 cells [1]. It inhibits SARS-CoV-2 replication in Vero E6 cells with an EC50 of 44 nM.
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CoV 3C-like (main) protease SARS-CoV-2 Inhibitor Inhibition 7.4 pKd - 1
pKd 7.4 (Kd 3.8x10-8 M) [1]
Description: Binding affinity
CoV 3C-like (main) protease SARS-CoV-2 Inhibitor Inhibition 7.1 pIC50 - 1
pIC50 7.1 (IC50 7.7x10-8 M) [1]
Description: Inhibtion of protease activity